Stocks Overview

LAST PRICE
59.0200
TODAY'S CHANGE (%)
Trending Down-1.8500 (-3.0393%)

Bid / Lots
58.2000/ 2
Ask / Lots
60.8000/ 1
Open / Previous Close
59.2000 / 60.8700
Day Range
Low 58.6315
High 60.4800
52 Week Range
Low 50.2700
High 67.3650
Volume
3,180,650
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 60.87
Time	Volume	INCY
09:32 ET	108385	60.48
09:34 ET	8145	59.98
09:36 ET	7379	59.86
09:38 ET	18908	59.66
09:39 ET	8119	59.86
09:41 ET	14385	59.6
09:43 ET	17695	59.61
09:45 ET	5826	59.31
09:48 ET	19145	58.81
09:50 ET	9043	59.02
09:52 ET	40179	59.1
09:54 ET	21922	59.03
09:56 ET	27538	58.965
09:57 ET	36482	59.02
09:59 ET	9200	58.8
10:01 ET	6715	58.775
10:03 ET	6360	58.78
10:06 ET	7734	58.805
10:08 ET	9544	58.82
10:10 ET	4619	58.805
10:12 ET	49625	58.7
10:14 ET	10688	58.845
10:15 ET	17754	58.975
10:17 ET	8318	58.87
10:19 ET	27834	58.805
10:21 ET	6745	58.96
10:24 ET	24973	59.23
10:26 ET	8165	59.14
10:28 ET	4332	59.05
10:30 ET	2301	58.96
10:32 ET	7789	59.01
10:33 ET	3686	59.09
10:35 ET	1808	59.01
10:37 ET	3394	59
10:39 ET	6336	59.11
10:42 ET	5180	59.06
10:44 ET	3380	59.06
10:46 ET	6914	59
10:48 ET	8400	59.16
10:50 ET	4055	59.145
10:51 ET	14785	59.2
10:53 ET	9882	59.25
10:55 ET	12361	59.43
10:57 ET	6112	59.48
11:00 ET	8888	59.49
11:02 ET	9531	59.58
11:04 ET	7268	59.51
11:06 ET	3443	59.38
11:08 ET	5806	59.28
11:09 ET	13505	59.08
11:11 ET	6078	59.065
11:13 ET	6123	59.08
11:15 ET	3669	59.145
11:18 ET	1083	59.145
11:20 ET	2967	59.05
11:22 ET	2117	59.1
11:24 ET	4702	59.17
11:26 ET	5556	59.19
11:27 ET	7348	59.355
11:29 ET	5042	59.4
11:31 ET	16438	59.55
11:33 ET	4411	59.6
11:36 ET	17253	59.52
11:38 ET	8754	59.56
11:40 ET	6051	59.4905
11:42 ET	2228	59.43
11:44 ET	6358	59.39
11:45 ET	8553	59.5
11:47 ET	2564	59.38
11:49 ET	9608	59.305
11:51 ET	5556	59.29
11:54 ET	4485	59.32
11:56 ET	14241	59.32
11:58 ET	8030	59.4
12:00 ET	11663	59.31
12:02 ET	5882	59.325
12:03 ET	4511	59.29
12:05 ET	4651	59.31
12:07 ET	6781	59.29
12:09 ET	3587	59.32
12:12 ET	4298	59.295
12:14 ET	3602	59.3
12:16 ET	3072	59.33
12:18 ET	4795	59.3
12:20 ET	3011	59.3
12:21 ET	7401	59.31
12:23 ET	12470	59.29
12:25 ET	4871	59.3
12:27 ET	1860	59.33
12:30 ET	2200	59.35
12:32 ET	2176	59.34
12:34 ET	11438	59.21
12:36 ET	2273	59.11
12:38 ET	2132	59.175
12:39 ET	2066	59.13
12:41 ET	1567	59.095
12:43 ET	608	59.08
12:45 ET	5440	59.17
12:48 ET	1939	59.16
12:50 ET	2103	59.115
12:52 ET	2603	59.1
12:54 ET	5100	59.14
12:56 ET	1545	59.1
12:57 ET	3399	59.07
12:59 ET	985	59.04
01:01 ET	667	59.0507
01:03 ET	1305	59.01
01:06 ET	2658	59.065
01:08 ET	1318	59.07
01:10 ET	4569	59.115
01:12 ET	1499	59.12
01:14 ET	2019	59.155
01:15 ET	1341	59.18
01:17 ET	3268	59.14
01:19 ET	3073	59.15
01:21 ET	4792	59.095
01:24 ET	2657	59.06
01:26 ET	2010	59.035
01:28 ET	1500	59.015
01:30 ET	4206	59.02
01:32 ET	3528	59.03
01:33 ET	9243	59.015
01:35 ET	3560	59.02
01:37 ET	4832	59.04
01:39 ET	2130	59.09
01:42 ET	2441	59.04
01:44 ET	4780	59.035
01:46 ET	2526	58.98
01:48 ET	2539	58.99
01:50 ET	2965	59
01:51 ET	5652	59.02
01:53 ET	3283	59.05
01:55 ET	5125	59.07
01:57 ET	1589	59.07
02:00 ET	2315	59.03
02:02 ET	7959	59.18
02:04 ET	3814	59.18
02:06 ET	5420	59.15
02:08 ET	2922	59.21
02:09 ET	3652	59.205
02:11 ET	2432	59.17
02:13 ET	1370	59.17
02:15 ET	5697	59.23
02:18 ET	4686	59.225
02:20 ET	8995	59.2599
02:22 ET	6224	59.25
02:24 ET	2446	59.28
02:26 ET	2781	59.29
02:27 ET	3105	59.32
02:29 ET	14339	59.36
02:31 ET	5881	59.29
02:33 ET	3818	59.31
02:36 ET	3534	59.33
02:38 ET	3881	59.345
02:40 ET	4224	59.39
02:42 ET	4518	59.35
02:44 ET	3189	59.31
02:45 ET	3365	59.35
02:47 ET	1059	59.34
02:49 ET	4167	59.32
02:51 ET	3613	59.31
02:54 ET	5066	59.16
02:56 ET	4467	59.19
02:58 ET	5204	59.24
03:00 ET	3161	59.23
03:02 ET	4600	59.2399
03:03 ET	4524	59.245
03:05 ET	2685	59.27
03:07 ET	4999	59.23
03:09 ET	1300	59.22
03:12 ET	1958	59.22
03:14 ET	4705	59.19
03:16 ET	3746	59.24
03:18 ET	2898	59.26
03:20 ET	4515	59.21
03:21 ET	4205	59.24
03:23 ET	4762	59.23
03:25 ET	7763	59.17
03:27 ET	4774	59.19
03:30 ET	3149	59.21
03:32 ET	7403	59.18
03:34 ET	5613	59.19
03:36 ET	7654	59.12
03:38 ET	7158	59.11
03:39 ET	8347	59.12
03:41 ET	9584	59.07
03:43 ET	9572	59.12
03:45 ET	10443	59.105
03:48 ET	12733	59.1
03:50 ET	16531	59.13
03:52 ET	18612	59.11
03:54 ET	21386	59.115
03:56 ET	65302	58.975
03:57 ET	71502	59.015
03:59 ET	924092	59.02

Data delayed at least 15 minutes.

Today
- DJ Incyte Cut to Underperform From Market Perform by BMO Capital, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
Jun 13, 2024
- Incyte Announces Final Results of Tender Offer, from 8:00AM ET on Thursday Jun 13, 2024 by Dow Jones
  8:00AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 11, 2024
- Incyte Announces Preliminary Results of Tender Offer, from 8:00AM ET on Tuesday Jun 11, 2024 by Dow Jones
  8:00AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 7, 2024
- Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Jun 07, 2024 by Dow Jones
  4:30PM ET on Friday Jun 07, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesINCY Incyte Corp	13.7B	17.9x	+39.11%
United StatesCRL Charles River Laboratories International Inc	10.5B	23.6x	+15.57%
United StatesUTHR United Therapeutics Corp	14.1B	15.0x	+8.22%
United StatesBGNE Beigene Ltd	15.7B	-19.0x	---
United StatesBMRN Biomarin Pharmaceutical Inc	15.6B	77.8x	---
United StatesBNTX Biontech SE	18.7B	154.2x	---
As of 2024-07-02

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs. The Company's pipeline also includes two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell mediated disorders and MRGPRX4 for cholestatic pruritus.

Contact Information

Headquarters: 1801 Augustine Cut-OffWILMINGTON, DE, United States 19803
Phone: 302-498-6700
Fax: 302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer: Herve Hoppenot
President and Head - Research and Development: Pablo Cagnoni
Chief Financial Officer, Executive Vice President: Christiana Stamoulis
Executive Vice President, General Counsel, Corporate Secretary: Sheila Denton
Executive Vice President, General Manager, Europe: Jonathan Dickinson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$13.7B
Revenue (TTM)	$3.8B
Shares Outstanding	224.5M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.73
EPS	$3.29
Book Value	$23.14
P/E Ratio	17.9x
Price/Sales (TTM)	3.6
Price/Cash Flow (TTM)	16.5x
Operating Margin	18.25%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Incyte Corp
NASDAQ:INCYUnited States

Search Criteria

Charts

Recent News

Today

DJ Incyte Cut to Underperform From Market Perform by BMO Capital, from 13 hours ago by Dow Jones

Jun 13, 2024

Incyte Announces Final Results of Tender Offer, from 8:00AM ET on Thursday Jun 13, 2024 by Dow Jones

Jun 11, 2024

Incyte Announces Preliminary Results of Tender Offer, from 8:00AM ET on Tuesday Jun 11, 2024 by Dow Jones

Jun 7, 2024

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Jun 07, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar